276 related articles for article (PubMed ID: 25028360)
1. Ultrastructural changes associated with dexamethasone-induced ocular hypertension in mice.
Overby DR; Bertrand J; Tektas OY; Boussommier-Calleja A; Schicht M; Ethier CR; Woodward DF; Stamer WD; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4922-33. PubMed ID: 25028360
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria and Autophagy Dysfunction in Glucocorticoid-Induced Ocular Hypertension/Glaucoma Mice Model.
Zeng W; Wang W; Wu S; Zhu X; Zheng T; Chen X; Ren J; Gong Y; Ke M
Curr Eye Res; 2020 Feb; 45(2):190-198. PubMed ID: 31425668
[No Abstract] [Full Text] [Related]
3. Perfusion-cultured bovine anterior segments as an ex vivo model for studying glucocorticoid-induced ocular hypertension and glaucoma.
Mao W; Tovar-Vidales T; Yorio T; Wordinger RJ; Clark AF
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8068-75. PubMed ID: 21911581
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor β2 (TGFβ2) signaling plays a key role in glucocorticoid-induced ocular hypertension.
Kasetti RB; Maddineni P; Patel PD; Searby C; Sheffield VC; Zode GS
J Biol Chem; 2018 Jun; 293(25):9854-9868. PubMed ID: 29743238
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone-Induced Ocular Hypertension in Mice: Effects of Myocilin and Route of Administration.
Patel GC; Phan TN; Maddineni P; Kasetti RB; Millar JC; Clark AF; Zode GS
Am J Pathol; 2017 Apr; 187(4):713-723. PubMed ID: 28167045
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma.
Patel GC; Millar JC; Clark AF
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1967-1978. PubMed ID: 31050723
[TBL] [Abstract][Full Text] [Related]
7. Identification of proteomic changes for dexamethasone-induced ocular hypertension using a tandem mass tag (TMT) approach.
Liang X; Li N; Rong Y; Wang J; Zhang H
Exp Eye Res; 2022 Mar; 216():108914. PubMed ID: 34979099
[TBL] [Abstract][Full Text] [Related]
8. Stanniocalcin-1 Reduced Intraocular Pressure in Two Models of Ocular Hypertension.
Roddy GW; Chowdhury UR; Monson KJ; Fautsch MP
Curr Eye Res; 2021 Oct; 46(10):1525-1530. PubMed ID: 33757401
[No Abstract] [Full Text] [Related]
9. Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model.
Kowal TJ; Prosseda PP; Ning K; Wang B; Alvarado J; Sendayen BE; Jabbehdari S; Stamer WD; Hu Y; Sun Y
Transl Vis Sci Technol; 2021 May; 10(6):10. PubMed ID: 34111256
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes.
Clark AF; Wilson K; de Kater AW; Allingham RR; McCartney MD
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):478-89. PubMed ID: 7843916
[TBL] [Abstract][Full Text] [Related]
11. Myocilin gene expression in the trabecular meshwork of rats in a steroid-induced ocular hypertension model.
Sawaguchi K; Nakamura Y; Nakamura Y; Sakai H; Sawaguchi S
Ophthalmic Res; 2005; 37(5):235-42. PubMed ID: 16020952
[TBL] [Abstract][Full Text] [Related]
12. Rho Kinase Inhibitor AR-12286 Reverses Steroid-Induced Changes in Intraocular Pressure, Effective Filtration Areas, and Morphology in Mouse Eyes.
Ren R; Humphrey AA; Kopczynski C; Gong H
Invest Ophthalmol Vis Sci; 2023 Feb; 64(2):7. PubMed ID: 36734964
[TBL] [Abstract][Full Text] [Related]
13. Effect of topical Ginkgo biloba extract on steroid-induced changes in the trabecular meshwork and intraocular pressure.
Jia LY; Sun L; Fan DS; Lam DS; Pang CP; Yam GH
Arch Ophthalmol; 2008 Dec; 126(12):1700-6. PubMed ID: 19064852
[TBL] [Abstract][Full Text] [Related]
14. BMP and Activin Membrane Bound Inhibitor Regulates the Extracellular Matrix in the Trabecular Meshwork.
Hernandez H; Millar JC; Curry SM; Clark AF; McDowell CM
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):2154-2166. PubMed ID: 29801150
[TBL] [Abstract][Full Text] [Related]
15. Expression of 14-3-3 Zeta Protein in Dexamethasone-Treated Mice and Human TM-1 Cells.
Liu Q; Ye Y; Lin X; Yang Y; Wu K; Yu M
Curr Eye Res; 2017 Aug; 42(8):1124-1129. PubMed ID: 28494163
[TBL] [Abstract][Full Text] [Related]
16. Increased intraocular pressure in mice treated with dexamethasone.
Whitlock NA; McKnight B; Corcoran KN; Rodriguez LA; Rice DS
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6496-503. PubMed ID: 20671272
[TBL] [Abstract][Full Text] [Related]
17. A rabbit model of age-dependant ocular hypertensive response to topical corticosteroids.
Qin Y; Lam S; Yam GH; Choy KW; Liu DT; Chiu TY; Li WY; Lam DS; Pang CP; Fan DS
Acta Ophthalmol; 2012 Sep; 90(6):559-63. PubMed ID: 21044276
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid receptor GRβ regulates glucocorticoid-induced ocular hypertension in mice.
Patel GC; Liu Y; Millar JC; Clark AF
Sci Rep; 2018 Jan; 8(1):862. PubMed ID: 29339763
[TBL] [Abstract][Full Text] [Related]
19. Relationships between Intraocular Pressure, Effective Filtration Area, and Morphological Changes in the Trabecular Meshwork of Steroid-Induced Ocular Hypertensive Mouse Eyes.
Ren R; Humphrey AA; Swain DL; Gong H
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055036
[TBL] [Abstract][Full Text] [Related]
20. The structure of the trabecular meshwork, its connections to the ciliary muscle, and the effect of pilocarpine on outflow facility in mice.
Overby DR; Bertrand J; Schicht M; Paulsen F; Stamer WD; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3727-36. PubMed ID: 24833737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
